D-cycloserine: A Novel Treatment for Gulf War Illness (GWDCS) | MicrobiomeTrials← Back to trialsNCT02983734
D-cycloserine: A Novel Treatment for Gulf War Illness (GWDCS)
CompletedPHASE2INTERVENTIONAL
Trial Details
Start: 2015-10Est. Completion: 2019-09-15
Enrollment target: 22 participants Locations- Boston University, Boston, Massachusetts, United States
Other microbiome trials you might be interested in
Gulf War Syndrome
The study addresses the pre-clinical promise of Montelukast (MLK) for improving brain function in veterans with Gulf War…
Houston, United StatesEst. completion Apr 2028
Gulf War Illness
Background:
Gulf War illness (GWI) affects up to 210,000 U.S. veterans who served in the Middle East during the Gulf Wa…
Bethesda, United StatesEst. completion Dec 31, 2030